NDC 70727-497

Rhopressa

Netarsudil

Rhopressa is a Ophthalmic; Topical Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Aerie Pharmaceuticals, Inc.. The primary component is Netarsudil Mesylate.

• Product ID: 70727-497_10ffc705-641e-4e75-8f2a-3a98cccbc471
• NDC: 70727-497
• Product Type: Human Prescription Drug
• Proprietary Name: Rhopressa
• Generic Name: Netarsudil
• Dosage Form: Solution/ Drops
• Route of Administration: OPHTHALMIC; TOPICAL
• Marketing Start Date: 2017-12-18
• Marketing Category: NDA / NDA
• Application Number: NDA208254
• Labeler Name: Aerie Pharmaceuticals, Inc.
• Substance Name: NETARSUDIL MESYLATE
• Active Ingredient Strength: 0 mg/mL
• Pharm Classes: Rho Kinase Inhibitor [EPC],Rho Kinase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 70727-497-25

1 BOTTLE in 1 CARTON (70727-497-25) > 2.5 mL in 1 BOTTLE

• Marketing Start Date: 2017-12-18
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70727-497-25 [70727049725]

Rhopressa SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA208254
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2017-12-18

NDC 70727-497-99 [70727049799]

Rhopressa SOLUTION/ DROPS

• Marketing Category: NDA
• Application Number: NDA208254
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2017-12-18

Drug Details

Active Ingredients

Ingredient	Strength
NETARSUDIL MESYLATE	.2 mg/mL

OpenFDA Data

• SPL SET ID: 7d4f0e3a-5b86-4c43-982a-813b22ae7e22
• Manufacturer:
  • Aerie Pharmaceuticals Inc.
• UNII:
  • VL756B1K0U
• RxNorm Concept Unique ID - RxCUI:
  • 1992873
  • 1992868

Pharmacological Class

• Rho Kinase Inhibitor [EPC]
• Rho Kinase Inhibitors [MoA]

Medicade Reported Pricing

70727049725 RHOPRESSA 0.02% OPHTH SOLUTION

Pricing Unit: ML | Drug Type: